How Does Smart Money Feel About Acura Pharmaceuticals, Inc. (ACUR)?

Page 2 of 2

With a general bullishness amongst the heavyweights, some big names have jumped into Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) headfirst. Deerfield Management created the most valuable position in Acura Pharmaceuticals, Inc. (NASDAQ:ACUR). Sabby Capital also initiated its position during the quarter.

Let’s go over hedge fund activity in other stocks similar to Acura Pharmaceuticals, Inc. (NASDAQ:ACUR). We will take a look at Luna Innovations Incorporated (NASDAQ:LUNA), SMTC Corporation (USA) (NASDAQ:SMTX), Deswell Industries, Inc. (NASDAQ:DSWL), and Skyline Corporation (NYSE:SKY). This group of stocks’ market valuations are closest to ACUR’s market valuation.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
LUNA 4 772 1
SMTX 5 4093 0
DSWL 4 2074 2
SKY 5 6416 1

As you can see these stocks had an average of 4.5 hedge funds with bullish positions and the average amount invested in these stocks was $3 million. That figure was $4 million in ACUR’s case. SMTC Corporation (USA) (NASDAQ:SMTX) is the most popular stock in this table, while Luna Innovations Incorporated (NASDAQ:LUNA) is the least popular one. Compared to these stocks Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) is even less popular than LUNA. Even though smart money isn’t very fond of this stock, that doesn’t necessarily mean it is overvalued and not a good investment. Further research may even suggest it is worth buying. However, before including it in your portfolio, more research is advisable.

Page 2 of 2